sub:assertion {
  d:DB00416 v:identifier "DB00416" ;
    v:namespace "drugbank" ;
    v:uri "http://bio2rdf.org/drugbank:DB00416" ;
    v:x-identifiers.org <http://identifiers.org/drugbank/DB00416> ;
    dv:drugbank-id "APRD01318" , "DB00416" ;
    dv:x-atc <http://bio2rdf.org/atc:M03AA04> ;
    dv:x-cas <http://bio2rdf.org/cas:7601-55-0> ;
    dv:x-chemspider <http://bio2rdf.org/chemspider:22666> ;
    dv:x-dpd <http://bio2rdf.org/dpd:466948> ;
    dv:x-kegg <http://bio2rdf.org/kegg:D00761> ;
    dv:x-pharmgkb <http://bio2rdf.org/pharmgkb:PA164749507> ;
    dv:x-pubchemcompound <http://bio2rdf.org/pubchem.compound:24244> ;
    dv:x-pubchemsubstance <http://bio2rdf.org/pubchem.substance:46507773> ;
    dct:description "Metocurine iodide is a benzylisoquinolinium competitive nondepolarizing neuromuscular blocking agent. It is used as an anesthesia adjunct to induce skeletal muscle relaxation and to reduce the intensity of muscle contractions in convulsive therapy Metocurine iodide has a moderate risk of inducing histamine release and has some ganglion blocking activity. Metocurine iodide can be used most advantageously if muscle twitch response to peripheral nerve stimulation is monitored to assess degree of muscle relaxation. Metocurine Iodide is no longer available on the US market."@en ;
    dct:identifier "drugbank:DB00416" ;
    dct:title "Metocurine Iodide"@en ;
    a dv:Drug ;
    rdfs:label "Metocurine Iodide [drugbank:DB00416]"@en ;
    rdfs:seeAlso <http://www.drugbank.ca/drugs/DB00416> .
}